Grants Awarded in 2013

Gene Therapy in a Mouse Model of Virus-triggered X-linked lymphoproliferative Disease (XLP1):
Control of Infection and Disease Progression
Peter Aichele, PhD
University Medical Center Freiburg, University of Freiburg - Freiburg, Germany

Dysregulation of Dendritic Cell Development in Langerhans Cell Histiocytosis
Matthew Collin, MD
Newcastle University - Newcastle upon Tyne, United Kingdom

Unraveling the Pathophysiological Role of the BRAFV600E Mutation in Langerhans Cell Histiocytosis (LCH) and its Therapeutical Implications with Murine Models of High Risk LCH
Miriam Merad, MD, PhD
Icahn School of Medicine at Mount Sinai - New York, New York USA

Janus Kinase Inhibition as a Novel Treatment for Hemophagocytic Lymphohistiocytosis
Kim E. Nichols, MD
The Children's Hospital of Philadelphia - Philadelphia, Pennsylvania USA

Histiocyte Society Clinical Trials Database System LCH-IV Treatment Protocol Study
Histiocyte Society Executive Board
LCH Study Reference Center - Vienna, Austria

Return to Grant Awards page